Your Ozempic® Pen: Understanding Doses and How Many Shots Are in One

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

An Ozempic® pen is a multi-dose delivery device that contains enough medication for approximately four weekly injections, representing a four-week supply. Most patients begin at a lower dose and gradually increase over several months as their body adapts. PlexusDx offers compounded semaglutide injection therapy starting at $189/mo (or $149/mo on the 6-month plan), providing the same active ingredient with personalized dosing guidance.

How Many Doses Are in One Ozempic® Pen

A standard Ozempic® pen holds 3 milliliters of liquid and delivers four individual 0.25-milligram, 0.5-milligram, 1-milligram, or 2-milligram doses depending on the pen strength. Each weekly injection uses one dose, meaning a single pen supplies one month of once-weekly treatment. The pen features a dial mechanism that patients rotate to set their weekly dose before each injection. This design helps ensure consistent, accurate delivery without needing to measure liquid manually. Patients typically receive a prescription for multiple pens to cover their entire treatment course.

Different pen strengths exist to support dose escalation protocols where patients start low and increase gradually. A 0.25-milligram starter pen contains four small doses suitable for initial tolerance, while higher-strength pens like 2-milligram are reserved for maintenance therapy after weeks of gradual increases. Your prescribing provider determines which pen strength matches your current dose level and timeline. PlexusDx compounded semaglutide injection offers flexible dosing without pen constraints, allowing your healthcare team to adjust amounts based on your response and goals.

Understanding GLP-1 Dose Escalation Schedules

Most GLP-1 therapy programs follow a four-week dose escalation pattern where patients increase their weekly injection by a fixed amount monthly until reaching their target maintenance dose. Clinical trials show that gradual escalation reduces nausea and gastrointestinal side effects compared to starting at higher doses immediately. A typical schedule might begin at 0.25 milligrams for week one, then increase to 0.5 milligrams in week five, advancing to 1 milligram in week nine, and reaching 2 milligrams by week thirteen. Some patients achieve their weight loss goals at intermediate doses and remain stable there rather than continuing to the maximum dose. Your individual response, tolerance, and health status determine whether you follow a standard schedule or a customized timeline.

The escalation approach works because GLP-1 receptors in your brain gradually adapt to the medication, reducing side effects while appetite suppression strengthens. Rushing through dose increases often leads to nausea and vomiting that can make treatment uncomfortable, while slow increases allow your body to develop tolerance. PlexusDx providers work with you to find your optimal therapeutic dose—the lowest amount producing your desired weight loss without intolerable side effects. This personalized approach means your dose may increase over time, but your treatment cost remains fixed at $149 per month for compounded semaglutide injection across all dose levels.

Comparing Ozempic® Pens to Compounded Alternatives

Ozempic® pens offer convenience and brand-name reliability but carry higher out-of-pocket costs if you lack insurance coverage or have high deductibles. Brand-name semaglutide typically costs $900 to $1,400 monthly without insurance, making it inaccessible for many people seeking weight loss treatment. Compounded semaglutide injection from licensed 503A pharmacies contains the identical active pharmaceutical ingredient but costs significantly less because it bypasses brand manufacturing and distribution markups. PlexusDx sources all medications exclusively from licensed 503A compounding pharmacies, ensuring quality standards while keeping your monthly cost at $189 flat regardless of dose level. No insurance is required, no membership fees apply, and treatment works for residents across all 50 states.

Licensed 503A compounding pharmacies follow strict FDA oversight and must meet sterility and potency standards equivalent to brand-name manufacturers. The clinical effectiveness of compounded semaglutide injection is identical to Ozempic® because the active ingredient and formulation are the same; cost differences reflect pharmacy business models, not medication quality. Some patients prefer pens for their simplicity, while others choose vials and syringes for flexibility and lower cost. PlexusDx can discuss which delivery method aligns with your preferences, medical history, and budget during your initial consultation with a licensed provider.

Tracking Your Dose Progress and Treatment Goals

Keeping a simple log of your weekly doses, injection dates, and how you feel helps you and your PlexusDx provider monitor your response to treatment. Record any side effects, appetite changes, weight shifts, and energy levels so your provider can make informed decisions about dose timing and increases. Many patients notice decreased hunger within days of starting, while appetite suppression deepens as doses rise over weeks. Weight loss typically appears gradual in the first four weeks but accelerates as you reach maintenance doses and your body adapts to lower calorie intake. Tracking also helps identify whether nausea or other side effects improve as your system adjusts, guiding decisions about continuing, staying at your current dose, or adjusting timing.

PlexusDx providers recommend monthly check-ins to review your progress, assess tolerability, and plan your next dose adjustment if appropriate. Your Precision Peptide Genetic Test results—available as a $99 add-on after your first month—provide genetic insights into how your body processes GLP-1 and related peptides, helping fine-tune your protocol. Testing maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights that explain individual responses to semaglutide and guide decisions about whether you might benefit from dual-therapy options like tirzepatide. This personalized approach helps you maximize results while minimizing side effects and unnecessary dose increases.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections are actually in one Ozempic® pen?

One Ozempic® pen contains four weekly doses, supplying exactly one month of once-weekly treatment. You rotate a dial on the pen to select each week's dose before injecting. After four injections, the pen is empty and you need a new one for the following month.

Does a higher dose in a pen cost more than a lower dose?

No. Ozempic® pen pricing depends on the pen strength, but with PlexusDx compounded semaglutide injection, your monthly cost stays flat at $189/mo (or $149/mo on the 6-month plan) regardless of dose level. Your dose may need to go up over time, but your price won't.

What clinical evidence supports gradual dose escalation for GLP-1 therapy?

Clinical trials show that slowly increasing semaglutide doses over four-week intervals reduces nausea and gastrointestinal side effects while maintaining weight loss effectiveness compared to rapid escalation. Gradual increases allow your GLP-1 receptors to adapt, improving tolerability and long-term adherence.

Can I switch from Ozempic® pens to PlexusDx compounded semaglutide?

Yes. Compounded semaglutide injection contains the same active ingredient as Ozempic® and is sourced from licensed 503A compounding pharmacies under strict FDA oversight. PlexusDx providers can transition you seamlessly while maintaining your current dose and schedule, then adjust as needed based on your response.

How does the Precision Peptide Genetic Test help optimize my dose?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.